The electrotherapy systems market size was valued at US$ 4.21 billion in 2022 and is expected to reach US$ 8.57 billion by 2030. The market is estimated to register a CAGR of 9.3% from 2022 to 2030.

An electrotherapy system is a medical device used to stimulate a patient's muscle function by passing electric currents through their tissues. Electrotherapy is useful in treating acute post-traumatic and post-surgical pain, facilitating wound healing and muscle spasm relaxation, preventing and mitigating disuse atrophy, aiding muscle rehabilitation, maintaining and increasing range of motion, and relieving acute post-traumatic and post-surgical pain. Electrotherapy units typically consist of a battery-operated device wired to adhesive electrode pads that make contact with the skin.

Noninvasive devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the electrotherapy systems market growth in the future.

By Product, Electrotherapy Systems Market-Based Insights

Based on the product, the electrotherapy systems market, is segmented into percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), micro-current therapy, interferential current therapy (IC), electro-acupuncture (EA), pulsed short wave diathermy (PSWD), transcutaneous spinal electroanalgesia (TSE), and others. The spinal cord stimulation segment held the largest share of the market in 2022. It is likely to register the highest CAGR during 2022-2030. Spinal cord stimulation has been in use in medical facilities for years. Cervical and lumbar radiculitis, failed back surgery syndrome, complex regional pain syndrome, and neuropathy are a few of the conditions that can be assisted by the therapy. Spinal cord stimulation is an efficacious, safe, and cost-effective method of chronic pain management.

By Application, Electrotherapy Systems Market - Based Insights

Based on the application, the electrotherapy systems market is segmented into neuromuscular dysfunction, pain management, acute and chronic edema, sports injury treatment, iontophoresis, urine and fecal incontinence, and others. The pain management segment held the largest share of the electrotherapy systems market share in 2022. It is likely to register the highest CAGR during 2022-2030. The market growth of this segment is attributed to the burgeoning prevalence of trauma and sports injuries. According to data released by the World Health Organization in March 2022, nearly 30 million children and teenagers participate in organized sports and more than 3.5 million injuries are reported every year. Furthermore, it was also estimated that 570,000 people faced traumatic pain in the US in 2021. An upsurge in the occurrence of back pain and neck pain also results in a heightened demand for electrotherapy to treat chronic pain.

Center for Disease Control and Prevention, and Brazilian Institute of Neuroscience and Neurotechnology are a few of the major primary and secondary sources referred to while preparing the report on the electrotherapy systems market.